back to overview
165
Tracking of second primary melanomas in vemurafenib-treated patients.
Dalle S, Poulalhon N, Debarbieux S, Zaharia D, Mihm MC, Lacouture ME, Rosen A, Marghoob AA, Busam KJ, Depaepe L, Bringuier PP, Richez P, Baurain JF, Bressac-de Paillerets B, Balme B, Thomas L.
ABSTRACT
PMID:23715012 DOI:10.1001/jamadermatol.2013.21
